1. Home
  2. Analysis
  3. Solu-cortef
  4. Apricot-kernel

Solu-cortef and Apricot kernel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Solu-cortef and Apricot kernel. Common interactions include angina pectoris among females.

The phase IV clinical study analyzes what interactions people who take Solu-cortef and Apricot kernel have. It is created by eHealthMe based on reports of 6 people who take Solu-cortef and Apricot kernel from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 03, 2022

6 people who take Solu-cortef and Apricot kernel together, and have interactions are studied.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 6,388 Solu-cortef users for its effectiveness, alternative drugs and more.

What is Apricot kernel?

Apricot kernel has active ingredients of apricot kernel. eHealthMe is studying from 62 Apricot kernel users for its effectiveness, alternative drugs and more.

Number of Solu-cortef and Apricot kernel reports submitted per year:

Solu-cortef and Apricot kernel drug interactions.

Common Solu-Cortef and Apricot Kernel drug interactions by gender *:

female:

  1. Angina pectoris
  2. Arthralgia
  3. Iron deficiency anaemia
  4. Nasopharyngitis
  5. Oedema
  6. Premenstrual syndrome
  7. Vulvovaginal candidiasis
  8. Gastroenteritis
  9. Upper respiratory tract infection
  10. Temporomandibular joint syndrome

male:

n/a

Common Solu-Cortef and Apricot Kernel drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Headache
  2. Hypertension
  3. Iron deficiency anaemia
  4. Nasopharyngitis
  5. Oedema
  6. Premenstrual syndrome
  7. Vulvovaginal candidiasis
  8. Gastroenteritis
  9. Upper respiratory tract infection
  10. Temporomandibular joint syndrome

40-49:

n/a

50-59:

n/a

60+:

  1. Pulmonary haemorrhage
  2. Sepsis

* Approximation only. Some reports may have incomplete information.

Do you take Solu-cortef and Apricot kernel?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Solu-cortef and Apricot kernel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Solu-cortef side effects:

Browse all side effects of Solu-cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Solu-cortef interactions:

Browse all interactions between Solu-cortef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone sodium succinate and apricot kernel (the active ingredients of Solu-cortef and Apricot kernel, respectively), and Solu-cortef and Apricot kernel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Solu-cortef and Apricot kernel.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.